Monday, 20 August 2018 - 13:37
  • it
  • de
  • en
  • fr


Pfizer must seek a mega-merger to keep growing

Pfizer’s shares have declined over 10% since August, while the Healthcare sector has only lost 5%, although Pfizer has been fairly active in M&A since August, having acquired Medivation ($14) and AstraZeneca’s antibiotic portfolio ($1.5bn). Besides, Pfizer announced in September…